Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002391435 | SCV002674136 | uncertain significance | Hereditary cancer-predisposing syndrome | 2020-10-01 | criteria provided, single submitter | clinical testing | The p.R2488T variant (also known as c.7463G>C), located in coding exon 14 of the BRCA2 gene, results from a G to C substitution at nucleotide position 7463. The arginine at codon 2488 is replaced by threonine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |